S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NewLink Genetics Corporation - NLNK|
|FDA Gives NewLink Genetics Approval to Proceed to Phase 1 Clinical Studies of Their Ebola Vaccine|
|NewLink Genetics Corporation Reports Second Quarter 2014 Financial Results|
|NewLink Genetics Corporation Announces Appointment of New Executive Vice President and Chief Financial Officer|
|NewLink Genetics Corporation, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From the Defense Threat Reduction Agency for Testing and Evaluation of Ebola Virus Vaccine|
|NewLink Genetics to Present at the XVIth International Congress of Virology|
|Getting Ebola treatments to market may take time (2014/10/1)|
|Inovio, GeneOne to move Ebola vaccine to human trials (2014/9/24)|
|UPDATE: Profiting from the fear as the market's best quarter of the year begins (2014/10/1)|
|Profiting from the fear as the market's best quarter of the year begins (2014/10/1)|
Click above to view more mutual fund data and stats for nlnk - NewLink Genetics Corp.